261 related articles for article (PubMed ID: 16893421)
21. Expression of genes encoding type IV collagen-degrading metalloproteinases and tissue inhibitors of metalloproteinases in various human tumor cells.
Sato H; Kida Y; Mai M; Endo Y; Sasaki T; Tanaka J; Seiki M
Oncogene; 1992 Jan; 7(1):77-83. PubMed ID: 1311064
[TBL] [Abstract][Full Text] [Related]
22. Platelet-derived growth factor and transforming growth factor-beta modulate the expression of matrix metalloproteinases and migratory function of human airway smooth muscle cells.
Ito I; Fixman ED; Asai K; Yoshida M; Gounni AS; Martin JG; Hamid Q
Clin Exp Allergy; 2009 Sep; 39(9):1370-80. PubMed ID: 19522858
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of the expression of metalloproteinases 2 and 9 and their tissue inhibitors in colon cancer cells treated with phytic acid.
Kapral M; Wawszczyk J; Jurzak M; Dymitruk D; Weglarz L
Acta Pol Pharm; 2010; 67(6):625-9. PubMed ID: 21229878
[TBL] [Abstract][Full Text] [Related]
24. Lipopolysaccharide-induced IL-12 expression in the central nervous system and cultured astrocytes and microglia.
Stalder AK; Pagenstecher A; Yu NC; Kincaid C; Chiang CS; Hobbs MV; Bloom FE; Campbell IL
J Immunol; 1997 Aug; 159(3):1344-51. PubMed ID: 9233631
[TBL] [Abstract][Full Text] [Related]
25. The effect of IL-1alpha on the expression of matrix metalloproteinases, plasminogen activators, and their inhibitors in osteoblastic ROS 17/2.8 cells.
Fujisaki K; Tanabe N; Suzuki N; Mitsui N; Oka H; Ito K; Maeno M
Life Sci; 2006 Mar; 78(17):1975-82. PubMed ID: 16313928
[TBL] [Abstract][Full Text] [Related]
26. [Involvement of matrix metalloproteinase-2, -9, and tissue inhibitors of metalloproteinase-1, 2 in occurrence of the accrete placenta].
Ke Y; Lu JH; Yang BL; Guo HQ; Ma QY; Zhu H; Shu HM; Li DJ
Zhonghua Fu Chan Ke Za Zhi; 2006 May; 41(5):311-4. PubMed ID: 16762185
[TBL] [Abstract][Full Text] [Related]
27. Effect of hormones on matrix metalloproteinases gene regulation in human aortic smooth muscle cells.
Grandas OH; Mountain DJ; Kirkpatrick SS; Rudrapatna VS; Cassada DC; Stevens SL; Freeman MB; Goldman MH
J Surg Res; 2008 Jul; 148(1):94-9. PubMed ID: 18570937
[TBL] [Abstract][Full Text] [Related]
28. Regulation of collagenase, stromelysin, and urokinase-type plasminogen activator in primary pterygium body fibroblasts by inflammatory cytokines.
Solomon A; Li DQ; Lee SB; Tseng SC
Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2154-63. PubMed ID: 10892857
[TBL] [Abstract][Full Text] [Related]
29. Effects of sulfasalazine and its metabolites on steady state messenger RNA concentrations for inflammatory cytokines, matrix metalloproteinases, and tissue inhibitors of metalloproteinase in rheumatoid synovial fibroblasts.
Minghetti PP; Blackburn WD
J Rheumatol; 2000 Mar; 27(3):653-60. PubMed ID: 10743803
[TBL] [Abstract][Full Text] [Related]
30. The balance between proteinases and inhibitors in a murine model of proliferative retinopathy.
Majka S; McGuire P; Colombo S; Das A
Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):210-5. PubMed ID: 11133870
[TBL] [Abstract][Full Text] [Related]
31. Endothelin-1-mediated signaling in the expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in astrocytes.
He S; Prasanna G; Yorio T
Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3737-45. PubMed ID: 17652746
[TBL] [Abstract][Full Text] [Related]
32. Substance P regulates the expression of matrix metalloproteinases and tissue inhibitors of metalloproteinase in cultured human gingival fibroblasts.
Cury PR; Canavez F; de Araújo VC; Furuse C; de Araújo NS
J Periodontal Res; 2008 Jun; 43(3):255-60. PubMed ID: 18179473
[TBL] [Abstract][Full Text] [Related]
33. Characterization of expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in prostate cancer cell lines.
Daja MM; Niu X; Zhao Z; Brown JM; Russell PJ
Prostate Cancer Prostatic Dis; 2003; 6(1):15-26. PubMed ID: 12664060
[TBL] [Abstract][Full Text] [Related]
34. Regulation of matrix metalloproteinases (MMPS) and their inhibitors (TIMPS) during mouse peri-implantation: role of nitric oxide.
Zhang X; Wang HM; Lin HY; Liu GY; Li QL; Zhu C
Placenta; 2004 Apr; 25(4):243-52. PubMed ID: 15028415
[TBL] [Abstract][Full Text] [Related]
35. Expression of matrix metalloproteinases in patients with Wegener's granulomatosis.
Bjerkeli V; Halvorsen B; Damås JK; Nordøy I; Yndestad A; Aukrust P; Frøland SS
Ann Rheum Dis; 2004 Dec; 63(12):1659-63. PubMed ID: 15547092
[TBL] [Abstract][Full Text] [Related]
36. Basement membrane remodeling in skeletal muscles of patients with limb ischemia involves regulation of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases.
Baum O; Ganster M; Baumgartner I; Nieselt K; Djonov V
J Vasc Res; 2007; 44(3):202-13. PubMed ID: 17337906
[TBL] [Abstract][Full Text] [Related]
37. Regulation of mRNAs encoding MMP-9 and MMP-2, and their inhibitors TIMP-1 and TIMP-2 by androgens in the rat ventral prostate.
Limaye AM; Desai KV; Chavalmane AK; Kondaiah P
Mol Cell Endocrinol; 2008 Nov; 294(1-2):10-8. PubMed ID: 18675881
[TBL] [Abstract][Full Text] [Related]
38. Cytokine-mediated modulation of MMPs and TIMPs in multipotential neural precursor cells.
Ben-Hur T; Ben-Yosef Y; Mizrachi-Kol R; Ben-Menachem O; Miller A
J Neuroimmunol; 2006 Jun; 175(1-2):12-8. PubMed ID: 16580738
[TBL] [Abstract][Full Text] [Related]
39. Interleukin-1beta and macrophage migration inhibitory factor (MIF) in dermal fibroblasts mediate UVA-induced matrix metalloproteinase-1 expression.
Honda A; Abe R; Makino T; Norisugi O; Fujita Y; Watanabe H; Nishihira J; Iwakura Y; Yamagishi S; Shimizu H; Shimizu T
J Dermatol Sci; 2008 Jan; 49(1):63-72. PubMed ID: 18060744
[TBL] [Abstract][Full Text] [Related]
40. Effect of cobalt and chromium ions on MMP-1, TIMP-1, and TNF-alpha gene expression in human U937 macrophages: a role for tyrosine kinases.
Luo L; Petit A; Antoniou J; Zukor DJ; Huk OL; Liu RC; Winnik FM; Mwale F
Biomaterials; 2005 Oct; 26(28):5587-93. PubMed ID: 15878362
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
